NCT04278118 2026-02-17
HiPPI
Emory University
Phase NA Recruiting
Clinical Trials
7 trialsNCT05439278 2025-05-21
Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
Severance Hospital
Phase 3 Recruiting
NCT06160206 2024-11-19
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
Academic and Community Cancer Research United
Phase 2 Recruiting
NCT01985087 2024-10-31
A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
University of Louisville
Phase 1/2 Active not recruiting
NCT03841435 2023-09-13
Hypofractionated Radiotherapy for Recurrent DIPG
University of Cincinnati
Phase NA Completed
NCT03778541 2019-07-23
HFSRT With Concurrent TMZ for Large BMs
ChineseAMS
Phase 3 Unknown
NCT03082846 2017-03-21
Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial
The Second Hospital of Hebei Medical University
Phase NA Completed